Levoleucovorin Injection, Solution
NDC 43598-773
Product Information
Levoleucovorin is a ANDA-approved product labeled by Dr.reddy's Laboratories Inc. This medication is used to treat or prevent serious blood cell disorders (such as thrombocytopenia, neutropenia, anemia) caused by certain drugs (folic acid antagonists such as methotrexate, trimethoprim, pyrimethamine). It is supplied as a injection, solution for intravenous administration. This product entry covers the primary NDC 43598-773 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 43598-773?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LEVOLEUCOVORIN CALCIUM (UNII: 778XL6VBS8)
- LEVOLEUCOVORIN (UNII: 990S25980Y) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1720765 - LEVOleucovorin 175 MG in 17.5 mL Injection
- RxCUI: 1720765 - 17.5 ML levoleucovorin 10 MG/ML Injection
- RxCUI: 1720765 - levoleucovorin (as levoleucovorin calcium) 175 MG per 17.5 mL Injection
- RxCUI: 1720765 - levoleucovorin 175 MG per 17.5 mL Injection
- RxCUI: 1720773 - LEVOleucovorin 250 MG in 25 ML Injection
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Levoleucovorin Injection
Levoleucovorin injection is used in adults and children to prevent harmful effects of methotrexate (Trexall) when methotrexate is used to treat osteosarcoma (cancer that forms in bones). Levoleucovorin injection is also used to treat adults and children who have accidentally received an overdose of methotrexate or similar medications or who are not able to eliminate these medications properly from their bodies. Levoleucovorin injection is also used with fluorouracil (5-FU, a chemotherapy medication) to treat adults with colorectal cancer (cancer that begins in the large intestine) that has spread to other parts of the body. Levoleucovorin injection is in a class of medications called folic acid analogs. It works to prevent the harmful effects of methotrexate by protecting healthy cells, while allowing methotrexate to enter and kill cancer cells. It works to treat colorectal cancer by increasing the effects of fluorouracil.
[Learn More]
* Please review the full disclaimer at the bottom of this page.